Roger H. Pak

938 total citations
15 papers, 558 citations indexed

About

Roger H. Pak is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Oncology. According to data from OpenAlex, Roger H. Pak has authored 15 papers receiving a total of 558 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 6 papers in Radiology, Nuclear Medicine and Imaging and 4 papers in Oncology. Recurrent topics in Roger H. Pak's work include Radiopharmaceutical Chemistry and Applications (4 papers), Boron Compounds in Chemistry (3 papers) and Chemical Synthesis and Analysis (2 papers). Roger H. Pak is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (4 papers), Boron Compounds in Chemistry (3 papers) and Chemical Synthesis and Analysis (2 papers). Roger H. Pak collaborates with scholars based in United States, United Kingdom and France. Roger H. Pak's co-authors include M. Frederick Hawthorne, Robert R. Kane, Satish Kumar Singh, Donna L. Luisi, Claude F. Meares, W. Robert Scheidt, Shaoguang Li, Cong Peng, Linghong Kong and David Grayzel and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Blood and Nature Nanotechnology.

In The Last Decade

Roger H. Pak

15 papers receiving 521 citations

Peers

Roger H. Pak
Jin‐Cong Zhuo Switzerland
Horrick Sharma United Kingdom
Eloisi Caldas-Lopes United States
Martin T. Haber United States
Juozas Domarkas United Kingdom
James M. Samanen United States
R.L. Childs United States
Jin‐Cong Zhuo Switzerland
Roger H. Pak
Citations per year, relative to Roger H. Pak Roger H. Pak (= 1×) peers Jin‐Cong Zhuo

Countries citing papers authored by Roger H. Pak

Since Specialization
Citations

This map shows the geographic impact of Roger H. Pak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roger H. Pak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roger H. Pak more than expected).

Fields of papers citing papers by Roger H. Pak

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roger H. Pak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roger H. Pak. The network helps show where Roger H. Pak may publish in the future.

Co-authorship network of co-authors of Roger H. Pak

This figure shows the co-authorship network connecting the top 25 collaborators of Roger H. Pak. A scholar is included among the top collaborators of Roger H. Pak based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roger H. Pak. Roger H. Pak is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
O’Brien, Matthew N., David A. Foley, Roger H. Pak, et al.. (2025). Chemistry, manufacturing and controls strategies for using novel excipients in lipid nanoparticles. Nature Nanotechnology. 20(3). 331–344. 15 indexed citations
2.
Singh, Satish Kumar, Donna L. Luisi, & Roger H. Pak. (2015). Antibody-Drug Conjugates: Design, Formulation and Physicochemical Stability. Pharmaceutical Research. 32(11). 3541–3571. 61 indexed citations
3.
Parker, Michael F., Joanne J. Bronson, Donna M. Barten, et al.. (2007). Amino-caprolactam derivatives as γ-secretase inhibitors. Bioorganic & Medicinal Chemistry Letters. 17(21). 5790–5795. 10 indexed citations
4.
Peng, Cong, Yiguo Hu, Linghong Kong, et al.. (2007). Inhibition of heat shock protein 90 prolongs survival of mice with BCR-ABL-T315I–induced leukemia and suppresses leukemic stem cells. Blood. 110(2). 678–685. 117 indexed citations
5.
Ge, Jie, Emmanuel Normant, James R. Porter, et al.. (2006). Design, Synthesis, and Biological Evaluation of Hydroquinone Derivatives of 17-Amino-17-demethoxygeldanamycin as Potent, Water-Soluble Inhibitors of Hsp90. Journal of Medicinal Chemistry. 49(15). 4606–4615. 143 indexed citations
6.
Peng, Cong, Yiguo Hu, Linghong Kong, et al.. (2006). IPI-504, a Novel, Orally Active HSP90 Inhibitor, Prolongs Survival of Mice with BCR-ABL T315I CML and B-ALL.. Blood. 108(11). 2183–2183. 2 indexed citations
7.
Peng, Cong, Yiguo Hu, Linghong Kong, et al.. (2006). Hsp-90 Inhibition Decreases Survival of BCR-ABL T315I Leukemic Stem Cells in Mice.. Blood. 108(11). 2184–2184. 1 indexed citations
8.
Peterson, Jim, Roger H. Pak, & Claude F. Meares. (1999). Total Solid-Phase Synthesis of 1,4,7,10-Tetraazacyclododecane-N,N,N,N-tetraacetic Acid-Functionalized Peptides for Radioimmunotherapy. Bioconjugate Chemistry. 10(2). 316–320. 34 indexed citations
9.
Pak, Roger H., Linda A. Kroger, Justin Moran, et al.. (1998). New Anti-Cu-TETA and Anti-Y-DOTA Monoclonal Antibodies for Potential Use in the Pre-Targeted Delivery of Radiopharmaceuticals to Tumor. Hybridoma. 17(2). 125–132. 21 indexed citations
10.
Primus, F. James, et al.. (1996). Bispecific Antibody Mediated Targeting of nido-Carboranes to Human Colon Carcinoma Cells. Bioconjugate Chemistry. 7(5). 532–535. 25 indexed citations
11.
Pak, Roger H., et al.. (1995). Preparation and properties of nido-carborane-specific monoclonal antibodies for potential use in boron neutron capture therapy for cancer.. Proceedings of the National Academy of Sciences. 92(15). 6986–6990. 36 indexed citations
12.
Brown, Julie, et al.. (1995). The performance of tethered and untethered forward facing child restraints. 23. 61–74. 12 indexed citations
13.
Pak, Roger H., Robert R. Kane, Carolyn B. Knobler, & M. Frederick Hawthorne. (1994). Synthesis and Structural Characterization of [Me3NH][nido-9,11-I2-7,8-C2B9H10] and [Me3NH][nido-9-I-7,8-C2B9H11]. Inorganic Chemistry. 33(23). 5355–5357. 32 indexed citations
14.
Kane, Robert R., Roger H. Pak, & M. Frederick Hawthorne. (1993). Solution-phase segment synthesis of boron-rich peptides. The Journal of Organic Chemistry. 58(5). 991–992. 22 indexed citations
15.
Pak, Roger H. & W. Robert Scheidt. (1991). Structure of (2,3,7,8,12,13,17,18-octaethylporphinato)copper(II). Acta Crystallographica Section C Crystal Structure Communications. 47(2). 431–433. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026